Daily Market Research Report

March 02, 2026

Alpha Signal Monitor

Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.

Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts

Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM

This report is generated using advanced AI research capabilities with real-time market data access.

Gold ETFs (GLD, IAU, BAR) — Institutional Outlook Snapshot as of March 2, 2026

Trading Idea: Buy Rationale (TL;DR): Consensus across major research houses is bullish into 2H26 on sustained central‑bank and private‑sector demand, expected declines in real rates, and ongoing geopolitical risk; upside targets for bullion span ~$5,400–$6,300/oz with only Citi remaining comparatively cautious. (finance.yahoo.com)

Gold entered 2026 near record highs after a 2025 demand-led surge. Banks flag central-bank purchases, renewed ETF participation, and scope for lower real rates as core supports; several houses have raised 2026 targets in January–February 2026. (jpmorgan.com)

Key Drivers - Official-sector (central bank) buying remains elevated versus pre‑2022 norms, supporting a structurally higher demand base. (jpmorgan.com) - Private‑sector diversification into bullion/ETFs on macro‑policy and geopolitical risks. (finance.yahoo.com) - Potential decline in US real yields lowers the opportunity cost of holding gold and can pull ETF inflows. (ubs.com) - USD vulnerability and policy uncertainty keep safe‑haven demand firm. (jpmorgan.com)

Risk Considerations - Hawkish Fed or a rise in real yields/stronger USD could sap ETF and investor demand. (in.investing.com) - De‑escalation of geopolitical risks or fiscal consolidation could compress the risk premium. (in.investing.com) - Volatility/sharp corrections remain possible even in an uptrend (e.g., early‑Feb selloff). (marketwatch.com) - Central‑bank buying could moderate from peak levels, reducing marginal support. (jpmorgan.com)

Bias long GLD/IAU/BAR on dips; consider scaling as macro catalysts unfold (central‑bank buying, easing real yields). Expect higher volatility, but institutional targets imply upside skew through 2H26; reassess if real yields/US dollar re‑accelerate or if official‑sector demand fades. (jpmorgan.com)

Stock Ratings — Street Targets & Ratings (GS, MS, JPM, BAC, C, WFC) — Tech Mega‑caps focus

Latest publicly reported price targets and ratings from Goldman Sachs (GS), Morgan Stanley (MS), JPMorgan (JPM), Bank of America (BAC), Citigroup (C), and Wells Fargo (WFC), compiled as of March 2, 2026. Where multiple notes exist, the most recent item we could source is shown. Ratings such as Overweight/Outperform are normalized to Buy; Equal‑Weight/Market Perform to Hold; Underperform to Sell. Key recent source examples for several entries include Investing.com, MarketBeat, Barron’s/IBD summaries, StreetInsider, and GuruFocus syndications. See each line item’s source URL for the primary reference. For example: AAPL—GS reiterated Buy, $330 on Feb 3, 2026; GOOGL—WFC to Overweight, PT $387 in late Feb 2026; MSFT—GS Buy, PT $655 in Jan 2026; AMZN—post Feb 6, 2026, most banks trimmed PTs but kept Buys.

AAPL - Apple Inc.

Most banks remain Buy/Overweight into 2026 with targets clustered ~$300–$330; latest bumps include GS to $330 (Feb 3, 2026) and JPM to $315 (Jan 26, 2026).

Consensus View - Rating: Buy, Target Price: 319.17 - 6/6 positive; average target ≈ $319.

MSFT - Microsoft Corp.

Broadly positive into 2026 on AI/Cloud; latest GS initiation/assumption at $655 (Jan 2026), MS at $650 (Jan 2026), JPM $550 (Jan 2026).

Consensus View - Rating: Buy, Target Price: 627.50 - 6/6 positive; average target ≈ $628.

GOOGL - Alphabet Inc.

Targets moved up post‑Q4 2025; GS to $400 (Feb 5, 2026); JPM to $395 (Feb 6, 2026); WFC upgraded to Overweight with $387 PT (late Feb 2026).

Consensus View - Rating: Buy, Target Price: 368.67 - 6/6 positive; average target ≈ $369.

AMZN - Amazon.com Inc.

After Feb 6, 2026 capex guide (~$200B 2026), most banks trimmed PTs but kept Buys; average across the six ≈ $284.

Consensus View - Rating: Buy, Target Price: 283.50 - 6/6 positive; average target ≈ $283.5.

NVDA - NVIDIA Corp.

Street still broadly bullish after Q4 beat; we found recent MS/JPM/WFC entries; others pending/behind paywalls in public sources.

Consensus View - Rating: Buy, Target Price: 198.33 - Across 3 of 6 banks located; average ≈ $198.3. Additional banks not publicly sourced in free channels.

META - Meta Platforms Inc.

Recent 2026 capex/AI build‑out created target dispersion; current cycle notes from requested six banks were not reliably available in public sources at time of compile.

Consensus View - Insufficient recent public-source data from the specified six banks.

TSLA - Tesla Inc.

Recent bank-specific target changes from the six requested institutions were not readily available in public sources during this compile window.

Consensus View - Insufficient recent public-source data from the specified six banks.

AVGO - AVGO Corp.

We could not reliably source recent public (non‑paywalled) notes from the specified six banks during this pass.

Consensus View - Insufficient recent public-source data from the specified six banks.

TSM - TSM Corp.

Recent firm‑specific targets from the six banks were not accessible in free sources at compile; can retrieve with additional time or paid-source access if needed.

Consensus View - Insufficient recent public-source data from the specified six banks.

Highlights

• AAPL: GS Buy/PT $330 (Feb 3, 2026); JPM Buy/PT $315 (Jan 26, 2026); BAC Buy/PT $325 (Jan 30, 2026).
• MSFT: GS Buy/PT $655 (Jan 20, 2026); MS Overweight/PT $650 (Jan 14, 2026); JPM Overweight/PT $550 (Jan 29, 2026).
• GOOGL: GS Buy/PT $400 (Feb 5, 2026); JPM Overweight/PT $395 (Feb 6, 2026); WFC Upgrade to Overweight/PT $387 (late Feb 2026).
• AMZN: Post Feb 6, 2026 capex update — GS $280 (Buy), MS $300 (Overweight), JPM $265 (Overweight), BAC $286 (Buy), C $265 (Buy), WFC $305 (Overweight).
• NVDA: Located MS $160 (OW), JPM $170 (OW), WFC $265 (OW); others pending public sourcing.

Notes: 1) Dates shown are the publication dates of the cited notes (local site timestamps). 2) Targets are in USD. 3) “Consensus” here is calculated across only the six named institutions when entries are present; when fewer than six are available, we average what’s present. 4) Many primary bank reports are behind paywalls; we cite reputable syndications (Investing.com, MarketBeat, StreetInsider, Barron’s/IBD, GuruFocus/Yahoo) that summarize those notes. If you want, I can keep digging for META/TSLA/AVGO/TSM across additional syndications or paid sources.

IPO Calendar

Timeframe: March 2, 2026 to April 2, 2026 (US equity markets)

As of Monday, March 2, 2026, there are no firm US operating‑company IPO pricings publicly scheduled for the next 1–2 weeks; several issuers cut sizes or postponed in late February amid a tech‑led selloff, keeping near‑term calendars thin. Expect day‑to‑day micro‑cap and SPAC activity with larger issuers waiting for volatility to subside. Pipeline momentum remains intact in biotech and select cross‑border tech/IT names, and multiple new SPACs filed in mid‑to‑late February. Separately, Bloomberg reporting indicates SpaceX may confidentially file as soon as March (a June listing is being discussed), underscoring a potentially more active late‑2Q window if markets stabilize. (investing.com)

Generate Biomedicines, Inc. (GENB)

• Exchange: Nasdaq (planned)
• Lead underwriters: Goldman Sachs, Morgan Stanley, Piper Sandler, Guggenheim Securities, Cantor Fitzgerald
• Business summary: Clinical‑stage biotech using an AI protein‑design platform; lead asset GB‑0895 (anti‑TSLP mAb) is in Phase 3 for severe asthma. Recently filed for a US IPO; terms and timing have not been set. (renaissancecapital.com)
• Notes: Filed Feb 4, 2026 with a $100 million placeholder; may launch a roadshow if market conditions improve. Listing date within the March window is uncertain. (renaissancecapital.com)
• Sources: Renaissance Capital: Generate Biomedicines files for a $100m US IPO (Feb 4, 2026). (renaissancecapital.com)

Salspera, Inc. (TKVA)

• Exchange: Nasdaq (planned)
• Lead underwriters: Kingswood Capital Markets
• Business summary: Immuno‑oncology company developing orally administered, engineered live biotherapeutics (e.g., Salmonella‑IL2) for solid tumors; lead program has completed a Phase 2 study in metastatic pancreatic cancer. Filed for a US IPO; no terms disclosed. (renaissancecapital.com)
• Notes: Filed Feb 2, 2026 with an $85 million placeholder; timing subject to market conditions. (renaissancecapital.com)
• Sources: Renaissance Capital: Salspera files for a US IPO (Feb 2, 2026). (renaissancecapital.com)

BAO Holding Limited (BAO)

• Price range: $4.00 – $5.00
• Shares offered: 3,800,000 shares (all common)
• Exchange: Nasdaq (planned)
• Lead underwriters: Pacific Century Securities, Revere Securities
• Business summary: Hong Kong‑based IT services firm providing software development and deployment of smart displays, kiosks, lockers and autonomous solutions. Refiled for a US IPO and reset terms in February. (renaissancecapital.com)
• Notes: Set terms on Feb 6, 2026; deal is day‑to‑day and could price quickly if markets cooperate. (renaissancecapital.com)
• Sources: Renaissance Capital: BAO Holding refiles, sets $17m US IPO terms (Feb 6, 2026). (renaissancecapital.com)

Cloud Data Holdings Limited (CDN)

• Price range: $4.00 – $4.50
• Shares offered: 3,800,000 shares (all common)
• Exchange: Nasdaq (planned)
• Lead underwriters: Cathay Securities
• Business summary: Hong Kong data‑center and internet infrastructure services provider spanning IDC services, connectivity and cloud support. Filed and set terms for a small US IPO. (renaissancecapital.com)
• Notes: Set terms Jan 21, 2026; timing is day‑to‑day; subject to Nasdaq approval and market conditions. (renaissancecapital.com)
• Sources: Renaissance Capital: Cloud Data Holdings files and sets terms for a $16m US IPO (Jan 21, 2026). (renaissancecapital.com)

CALM Chain International Limited (TalentQuest) (CCIL)

• Price range: $5.00 – $7.00
• Shares offered: 3,000,000 shares (33% secondary)
• Exchange: Nasdaq (planned)
• Lead underwriters: Pacific Century Securities
• Business summary: Hong Kong–based HR services firm providing employer‑of‑record (EoR), HR outsourcing, executive search and workforce research for cross‑border clients. Set terms for a US IPO. (renaissancecapital.com)
• Notes: Filed Feb 10, 2026; listing date not yet scheduled. (renaissancecapital.com)
• Sources: Renaissance Capital: CALM Chain International files; sets $18m US IPO terms (Feb 10, 2026). (renaissancecapital.com)

PayPay Corporation (PAYP)

• Exchange: Nasdaq (planned)
• Lead underwriters: Goldman Sachs, J.P. Morgan, Mizuho Securities, Morgan Stanley, Citi, Jefferies, BofA Securities, Société Générale, Nomura, Cantor Fitzgerald, Crédit Agricole CIB, Daiwa Securities, Deutsche Bank, Natixis, SMBC Nikko
• Business summary: Japan‑based mobile payments and digital financial services platform (payments, credit card, banking and brokerage) planning a sizable US listing. Filed in mid‑February; no terms yet. (renaissancecapital.com)
• Notes: Filed Feb 12, 2026; deal size estimated up to ~$2.0 billion by Renaissance Capital; launch timing TBD and sensitive to market tone. (renaissancecapital.com)
• Sources: Renaissance Capital: PayPay files for an estimated $2.0b US IPO (Feb 12, 2026). (renaissancecapital.com)

TRG Latin America Acquisitions Corp. (TRGSU)

• Price range: $10.00 per unit
• Shares offered: 20,000,000 units (each unit: 1 share + 1 right for 1/10 share)
• Exchange: Nasdaq (planned)
• Lead underwriters: Santander
• Business summary: SPAC sponsored by The Rohatyn Group targeting Latin America, with a particular focus on Argentina across energy, mining, agribusiness and tech‑enabled services. Filed for a $200 million IPO. (renaissancecapital.com)
• Notes: Filed Feb 10, 2026; SPAC IPOs often price on short notice; date within the month is possible but unconfirmed. (renaissancecapital.com)
• Sources: Renaissance Capital: TRG Latin America Acquisitions files $200m SPAC (Feb 10, 2026). (renaissancecapital.com)

NewHold Investment IV Corp. (NHIVU)

• Price range: $10.00 per unit
• Shares offered: 17,500,000 units (each unit: 1 share + 1/3 warrant @ $11.50)
• Exchange: Nasdaq (planned)
• Lead underwriters: BTIG
• Business summary: SPAC targeting industrial technology (transportation, distribution, manufacturing, robotics) led by NewHold Enterprises executives. Filed for a $175 million IPO. (renaissancecapital.com)
• Notes: Filed Feb 18, 2026; may price day‑to‑day depending on demand. (renaissancecapital.com)
• Sources: Renaissance Capital: NewHold Investment IV files $175m SPAC (Feb 18, 2026). (renaissancecapital.com)

Forefront Tech Holdings Acquisition Corp. (FTHAU)

• Price range: $10.00 per unit
• Shares offered: 10,000,000 units (each unit: 1 share + 1/2 warrant @ $11.50)
• Exchange: Nasdaq (planned)
• Lead underwriters: BTIG
• Business summary: SPAC focused on blockchain‑enabled AI, digital trade identities and robotics; led by Peter Bilitsch (ex‑Mobiv Acquisition). Filed for a $100 million IPO. (renaissancecapital.com)
• Notes: Filed Feb 19, 2026; typical SPAC timing would allow a March pricing if markets permit. (renaissancecapital.com)
• Sources: Renaissance Capital: Forefront Tech Holdings Acquisition files $100m SPAC (Feb 19, 2026). (renaissancecapital.com)

Space Exploration Technologies Corp. (SpaceX)

• Business summary: Privately held space launch and satellite communications company (Starlink) reportedly weighing a confidential US IPO filing as soon as March; some reports discuss a potential mid‑June listing window if pursued. Highly tentative and subject to change. (sg.finance.yahoo.com)
• Notes: Not filed publicly as of March 2, 2026; timing, structure (IPO vs. carve‑out), exchange and bookrunners remain unconfirmed. Included as a watchlist item due to potential March confidential filing. (sg.finance.yahoo.com)
• Sources: Bloomberg via Yahoo Finance: SpaceX weighing confidential IPO filing as soon as March (Feb 27, 2026). (sg.finance.yahoo.com), Financial Times: reporting on a potential mid‑June timeline (context only; unconfirmed). (ft.com)

IPO calendars change quickly and US deals are often confirmed 7–10 days before pricing; micro‑caps and SPACs can appear intra‑week. Several February candidates postponed or downsized (e.g., Clear Street), so March activity is especially sensitive to market tone. We will update this view as exchanges and underwriters post new launches. (investing.com)

Sources

• Stock Ratings: https://es.investing.com/news/analyst-ratings/goldman-sachs-mantiene-el-precio-objetivo-de-microsoft-en-655-dolares-93CH-3473039, https://es.investing.com/news/analyst-ratings/jpmorgan-reduce-el-precio-objetivo-de-las-acciones-de-microsoft-a-550-dolares-por-valoracion-93CH-3489327, https://it.investing.com/news/analyst-ratings/wells-fargo-alza-il-target-di-prezzo-delle-azioni-nvidia-a-265-grazie-alle-prospettive-di-crescita-dellia-93CH-3098409, https://m.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-apple-stock-with-330-price-target-93CH-4482636?ampMode=1, https://pl.investing.com/news/analyst-ratings/goldman-sachs-obniza-cene-docelowa-akcji-amazona-do-280--z-powodu-cyklu-inwestycyjnego-93CH-1270315, https://www.gurufocus.com/news/4088535/apple-stock-in-focus-wells-fargo-keeps-overweight-rating-ahead-of-2026, https://www.gurufocus.com/news/4102202/wells-fargo-adjusts-price-target-for-microsoft-msft-to-665-msft-stock-news, https://www.gurufocus.com/news/8591762/googl-citigroup-raises-price-target-maintains-buy-rating-googl-stock-news, https://www.gurufocus.com/news/8599176/amzn-citigroup-lowers-price-target-but-maintains-buy-rating-amzn-stock-news, https://www.investing.com/news/analyst-ratings/amazon-stock-price-target-lowered-to-286-by-bofa-on-aws-outlook-93CH-4466651, https://www.investing.com/news/analyst-ratings/apple-stock-price-target-raised-to-315-from-305-at-jpmorgan-93CH-4465277, https://www.investing.com/news/analyst-ratings/bofa-securities-raises-microsoft-stock-price-target-to-585-on-azure-strength-93CH-4142222, https://www.investing.com/news/analyst-ratings/bofa-securities-reiterates-buy-rating-on-apple-stock-with-325-price-target-93CH-4475321, https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-alphabet-stock-price-target-to-400-on-strong-cloud-growth-93CH-4486851, https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-nvidia-stock-overweight-with-170-target-93CH-3896874, https://www.investing.com/news/analyst-ratings/morgan-stanley-maintains-nvidia-stock-overweight-rating-160-target-93CH-4053152, https://www.investing.com/news/analyst-ratings/morgan-stanley-reiterates-overweight-rating-on-microsoft-stock-at-650-93CH-4446158, https://www.investing.com/news/stock-market-news/alphabet-stock-from-structural-question-marks-to-ai-winner-4268906, https://www.investing.com/news/stock-market-news/apple-price-target-raised-at-morgan-stanley-in-2026-it-hardware-outlook-4413024, https://www.investing.com/news/stock-market-news/citi-raises-apple-price-target-on-firmer-upgrade-cycle-iphone-17-strength-4398652, https://www.investors.com/news/technology/google-stock-wells-fargo-upgrades-ai-winner/, https://www.marketbeat.com/instant-alerts/alphabet-nasdaqgoogl-given-new-39500-price-target-at-jpmorgan-chase-co-2026-02-05/, https://www.marketbeat.com/instant-alerts/alphabet-nasdaqgoogl-trading-up-12-following-analyst-upgrade-2026-01-13/, https://www.marketbeat.com/instant-alerts/citigroup-cuts-microsoft-nasdaqmsft-price-target-to-66000-2026-01-21/, https://www.marketbeat.com/instant-alerts/wells-fargo-company-increases-amazoncom-nasdaqamzn-price-target-to-30500-2026-02-06/, https://www.marketwatch.com/story/how-amazons-underappreciated-ai-potential-could-drive-the-stock-50-higher-1a4aa628, https://www.tipranks.com/news/the-fly/amazon-com-price-target-lowered-to-265-from-305-at-jpmorgan-thefly
• IPO Calendar: https://sg.finance.yahoo.com/news/spacex-weighing-confidential-ipo-filing-195649199.html?utm_source=openai, https://www.ft.com/content/0ee356cb-5c77-4686-9392-260520369122?utm_source=openai, https://www.investing.com/news/stock-market-news/factboxcompanies-rethink-ipos-in-2026-as-volatility-tests-valuations-4508749?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/116330/Hong-Kong-data-center-services-provider-Cloud-Data-Holdings-files-and-set-t?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/116681/Immuno-oncology-biotech-Salspera-files-for-a-US-IPO?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/116750/Asthma-focused-AI-biotech-Generate-Biomedicines-files-for-a-%24100-million-US?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/116826/Hong-Kong-based-IT-services-firm-BAO-Holding-refiles-for-a-%2417-million-US-I?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/116892/Hong-Kong-based-human-resources-services-firm-CALM-Chain-International-file?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/116904/SPAC-TRG-Latin-America-Acquisitions-files-for-a-%24200-million-US-IPO-focusin?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/116979/Japanese-fintech-PayPay-files-for-an-estimated-%242.0-billion-US-IPO?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/117110/SPAC-NewHold-Investment-IV-files-for-a-%24175-million-IPO-targeting-industria?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/117148/SPAC-Forefront-Tech-Holdings-Acquisition-files-for-a-%24100-million-IPO-targe?utm_source=openai

Disclaimer

This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.

Generated on: 2026-03-02 at 11:30 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.

Powered by Alpha Signal Monitor | Market Intelligence Through AI